Report Publication Announcement • Jan 9, 2017
Report Publication Announcement
Open in ViewerOpens in native device viewer
Photocure to present at investor meetings in San Francisco
Oslo, Norway, January 9, 2017
Photocure ASA (OSE: PHO) management is this week
conducting investor meetings in San Francisco (US) in
connection with the J.P. Morgan healthcare conference.
Please find the presentation attached.
About Photocure ASA
Photocure, headquartered in Oslo Norway, is a
specialty pharmaceutical company and world leader in
photodynamic technology. Based on our unique
proprietary Photocure Technology® platform, Photocure
develops and commercializes highly selective and
effective solutions within disease areas with high
unmet medical need, such as bladder cancer, HPV and
precancerous cervical lesions and skin conditions. Our
aim is to provide solutions which can improve health
outcomes for patients worldwide. Photocure is listed
on the Oslo Stock Exchange (OSE: PHO). Information
about Photocure is available at www.photocure.com.
For more information, please contact:
Photocure
Erik Dahl
Chief Financial Officer
Tel: +47 450 55 000
Email: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.